Filter by
Filter by
The Unhindered Patient Journey to Proton Therapy
How can you ensure an optimized workflow for treatment delivery? Watch this webinar with our industry partner Elekta to learn how we’ve optimized user...
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.
This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...
Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.
To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy.
A review summarized FLASH radiotherapy research conducted to date and the current theories explaining the FLASH effect, with an emphasis on the future potential...
Comparing bowel and urinary domains of patient-reported quality of life at the end of and 3 months post radiotherapy between intensity-modulated radiotherapy and proton beam therapy for clinically localized prostate cancer.
This study compared the bowel function (BF), urinary irritative/obstructive symptoms (UO), and urinary incontinence (UI) domains of EPIC-26 collected in 262...
Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam therapy in uveal melanoma.
Published in the Green Journal, this study compared two cohorts of each 153 patients with uveal melanoma treated with fractionated stereotactic photon-RT (50 Gy...